Blog

Questionnaires sent out by researchers from the American Society for Aesthetic Plastic Surgery (ASAPS) have given us some insight about why patients choose wrinkle treatments. Researchers sent the surveys out last March to 687 patients who had received Botox and/or dermal filler treatment. 

The following statistics illustrate the opinions of the ‘typical’ patient. Who is the ‘typical’ patient?  According to the results, she is “a married, working mother between 41-55 years of age with a household income of under $100,000.”

• Roughly 70 percent of the respondents claimed that Botox and dermal fillers play an important role in their cosmetic routine.  About the same number of respondents said they used both Botox and wrinkle fillers.  
• When asked what their motivation was for pursuing Botox treatment, 34 percent said their appearance looked “stressed” or “angry”. Others said that a friend, family member, or their physician had recommended it, or they were preparing for a social event.
• 66 percent said they received Botox treatment 2-3 times per year. 72 percent of the respondents chose Botox to treat glabellar lines – the vertical lines that appear between your eyebrows.  
• When asked about their motivation to use hyaluronic acid fillers, the majority (63 percent) of patients reported a desire to remove facial wrinkles and folds – mostly the nasolabial folds that travel from the nose to each side of the mouth.

A full summary of the results is available (in MS Word) here.

Doctors once believed that off-label use of Botox – a drug developed for treating muscles spasms – would be fairly limited. If you do a little research however, you’ll find that physicians are using the neurotoxin for many other interesting purposes.

Last March, the New York Times published a story on the off-label use of Botox to help those who have suffered a stroke and have trouble relaxing certain muscles. According to the experts, “only about 5 percent of the stroke patients who could benefit from its use ever get it.”

Many doctors use Botox to treat headaches, and their basic procedures are hardly different than those of wrinkle treatment. It isn’t entirely clear how the Botulinum toxin provides relief; it may work to inhibit certain pain-transmitting nerves. But evidently, many people suffer from fewer headaches after being treated with Botox.

As reported in the Journal of the American Academy of Dermatology, researchers from Allergan Inc. conducted surveys about sweating, revealing that almost 3 percent of the U.S. population (7.8 million people) believe their sweating to be excessive. At the time of the survey (in 2004), less than half of the respondents had sought medical help for the problem. Botox blocks the localized release of a specific chemical that stimulates sweating, and so the FDA approved it for this use years ago.

Patients with even more obscure conditions have found success using Botox. In Feb 2008, USA Today reported that radio personality Diane Rehm (of National Public Radio) had received routine off-label Botox treatments for a vocal disorder called spasmodic dysphonia.

Aside from these therapies, surgeons and dermatologists are finding even more cosmetic uses for Botox.  Dr. Lawrence Reed recently told an ABC news affiliate that “we’re at the tip of the iceberg where Botox is going to be used.” Reed has apparently been pioneering some interesting new cosmetic applications.  For patients with acne, Dr. Reed injects Botox just below the skin: “It decreases the muscle pump and blocks the production of oils, so we use it for acne,” he claims. Other patients of Dr. Reed found received Botox to relax certain muscles (one patient made her eyes appear larger) and to supplement laser skin resurfacing.

Just a few words of caution:  If you’re considering Botox for any off-label use, make sure you choose a qualified physician. Despite the optimism surrounding Botox as a ‘wonder drug’, there have been complications and side effects associated with off-label use and inexperienced providers.  If you’re interested in Botox treatment around Maple Valley, Washington, contact us, or see our homepage.

On the first of December, breast implant and cosmetic specialties supplier Mentor corp (MNT) announced a deal to be acquired by Johnson and Johnson, for the price of $1.1 billion.

While Mentor is mostly focused on providing breast implants, FDA approval is expected in 2010 for their new wrinkle reducing injectable, PurTox. Since it is similarly derived from the botulinum toxin, the drug is supposed to compete with the well-known wrinkle relaxer, Botox.

With the recently troubled market, Mentor tried to boost sales of silicone breast implants, which had typically generated double the revenue of comparable saline implants since the FDA lifted the ban on them two years ago.

A JP Morgan analyst said that the acquisition by JNJ was a result of recent economic issues faced by Mentor Corp. – issues which ultimately forced them to succumb to the deal.